Literature DB >> 27504760

Juno's wild ride.

Laura DeFrancesco.   

Abstract

Year:  2016        PMID： 27504760     DOI： 10.1038/nbt0816-793

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  5 in total

1.  CAR-T cells forge ahead, Novartis reorganizes.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2016-11-08       Impact factor: 54.908

2.  CAR-T Cells: A Systematic Review and Mixed Methods Analysis of the Clinical Trial Landscape.

Authors:  David Pettitt; Zeeshaan Arshad; James Smith; Tijana Stanic; Georg Holländer; David Brindley
Journal:  Mol Ther       Date:  2017-11-02       Impact factor: 11.454

Review 3.  Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatment.

Authors:  Zhenguang Wang; Yelei Guo; Weidong Han
Journal:  Protein Cell       Date:  2017-05-02       Impact factor: 14.870

Review 4.  Clinical development of CAR T cells-challenges and opportunities in translating innovative treatment concepts.

Authors:  Jessica Hartmann; Martina Schüßler-Lenz; Attilio Bondanza; Christian J Buchholz
Journal:  EMBO Mol Med       Date:  2017-09       Impact factor: 12.137

Review 5.  Current Progress in CAR-T Cell Therapy for Solid Tumors.

Authors:  Shuo Ma; Xinchun Li; Xinyue Wang; Liang Cheng; Zhong Li; Changzheng Zhang; Zhenlong Ye; Qijun Qian
Journal:  Int J Biol Sci       Date:  2019-09-07       Impact factor: 6.580
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.